Insulet

Insulet

Yahoo Finance • yesterday

1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid

1 of Wall Street's Favorite Stocks for Long-Term Investors and 2 We Avoid The stocks in this article have caught Wall Street's attention in a big way, with price targets implying returns above 20%. But investors should take these forecast... Full story

Yahoo Finance • 4 days ago

Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin

Insulet Corporation (NASDAQ:PODD) is one of the most promising healthcare stocks according to Wall Street analysts. On June 6, Insulet Corporation (NASDAQ:PODD) released new clinical results for two of its next-generation diabetes manageme... Full story

Yahoo Finance • 11 days ago

2 S&P 500 Stocks to Target This Week and 1 That Underwhelm

2 S&P 500 Stocks to Target This Week and 1 That Underwhelm The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are c... Full story

Yahoo Finance • 12 days ago

Stock index futures surge buoyed by U.S.-Iran peace deal

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were sharply higher on Monday as the U.S. and Iran announced a long-awaited peace agreement that would restore shipping through the Strait of Hor... Full story

Yahoo Finance • 18 days ago

Monday 6/8 Insider Buying Report: PODD, ADC

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is th... Full story

Yahoo Finance • 19 days ago

Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option

Insulet Corporation (NASDAQ:PODD) is one of the oversold stocks to buy right now. On June 3, Insulet launched significant enhancements to its Omnipod 5 Automated Insulin Delivery/AID System in the US, featuring a new 100 mg/dL Target Gluco... Full story

Yahoo Finance • 22 days ago

Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?

In early June 2026, Insulet began rolling out FDA-cleared algorithm enhancements to its Omnipod 5 Automated Insulin Delivery System in the U.S., adding a 100 mg/dL target option and new compatibility with Abbott’s Libre 3 Plus sensor via o... Full story

Yahoo Finance • 22 days ago

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and treatment, DexCom (NASDAQ:DXCM) and Insulet (NASDA... Full story

Yahoo Finance • 24 days ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor

Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve time in range and stay in Automated Mode longer Omnipod 5 is now compatible with Abbott’s Libre 3 Plus sensor in U.S., giving users more c... Full story

Yahoo Finance • 25 days ago

Insulet Corporation (PODD) Initiates Voluntary Correction For Certain Omnipod Devices

Insulet Corporation (NASDAQ:PODD) is among the 10 Most Oversold S&P 500 Stocks So Far in 2026. The company is carrying out a voluntary correction for specific lots of Omnipod 5, Omnipod DASH, and Omnipod Insulin Management System, it said... Full story

Yahoo Finance • 26 days ago

Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus

Wall Street pushed higher on Friday and closed at record highs across all three major averages. For the week, the Nasdaq Composite climbed 2.4%, the S&P 500 moved up 1.4%, and the Dow added 0.9%. The S&P 500 Health Care Index Sector (XLV... Full story

Yahoo Finance • 27 days ago

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Soleus Capital Management disclosed a significant buy of Vericel(NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average pricing—according to a May 14, 2026, SEC filing. What... Full story

Yahoo Finance • last month

Stocks making the biggest moves after hours: Zscaler, Insulet, Box and more

Check out the companies making headlines after the bell : Box — The cloud-based content management provider slipped 2% after guiding for full-year adjusted earnings of $1.56 per share, while analysts polled by LSEG were expecting $1.63. Ho... Full story

Yahoo Finance • last month

Here’s Insiders Fund’s Thesis on Insulet Corporation (PODD)

Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund lost 7.14% in the quarter, tied to a 6.75% fall in March due to the War i... Full story

Yahoo Finance • last month

Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

Company Logo The Middle East and Africa wearable injectors market is poised for growth, driven by increasing chronic disease prevalence and healthcare advancements. Key opportunities include rising demand for self-administration devices,... Full story

Yahoo Finance • last month

Why Goldman Sachs Trimmed Insulet Corporation (PODD) Price Target Despite Strong Q1 Results

We recently compiled a list of the 8 Most Oversold Large Cap Stocks to Buy. Insulet Corporation (NASDAQ:PODD) is one of the most oversold stocks. TheFly reported on May 7 that PODD saw its valuation outlook revised as Goldman Sachs reduce... Full story

Yahoo Finance • last month

Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Lowe's(LOW) to Buy from... Full story

Yahoo Finance • last month

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More

Quick Read: Despite President Trump rejecting Iran’s counterproposal, stocks rose on Monday. Enthusiasm over Artificial Intelligence and a stellar first-quarter earnings season were cited among the reasons for the continued strength. With... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus

Wall Street’s major market averages ended higher on Friday as investors digested the latest nonfarm payrolls print and sidestepped the ongoing tensions in the Middle East. The blue-chip Dow added +0.1%, the benchmark S&P 500 closed +0.8%,... Full story

Yahoo Finance • 2 months ago

Most healthcare companies report higher Y/Y EPS in strong earnings week

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare companies delivered strong earnings this week, with 18 out of 20 companies beating EPS estimates and 15 t... Full story